Precision BioLogic Inc. is Set for Future Growth in Dartmouth

Sep 23, 2009

A Dartmouth-based life sciences company is creating new opportunities for some of Nova Scotia's brightest graduates and seasoned professionals.

 Precision BioLogic Inc. is expanding its Dartmouth operations and plans to create up to 30 jobs in the next five years. The province, through Nova Scotia Business Inc. (NSBI) is supporting the company's growth plans with a five-year payroll rebate for up to a maximum of $445,029.

 "Precision BioLogic is a homegrown company that is reaching markets around the globe," said Minister of Economic and Rural Development Percy Paris. "The company is creating high-quality career opportunities for Nova Scotians and we couldn't be happier to partner with them." 

 Precision BioLogic is one of many companies participating in BioPort Atlantic 2009, a conference held by the Nova Scotia Biotechnology and Life Sciences Industry Association which starts tonight until Sept. 24.

 "We're excited to be growing our business here in Nova Scotia," said Michael Scott, CEO and chairman, Precision BioLogic. "We pride ourselves on the quality of our products and our superior customer service.  This focus, in conjunction with our dedicated employees, is a key reason for our continued growth."

 Precision BioLogic develops, manufactures and markets diagnostic products used to test blood clotting abnormalities. Patients waiting for surgical procedures as well as those with a high risk of heart attack or stroke benefit from these types of tests. The company is known worldwide for its innovative and high quality products.

 "Precision BioLogic is building on Nova Scotia's strengths -innovative business, skilled and talented people, and competitive success in export markets around the world," said Stephen Lund, president and CEO, Nova Scotia Business Inc.

 Marli MacNeil, CEO of BioNova, the province's life sciences association said news of the expansion is evidence of the potential for the province's industry. "This is good news for the entire industry," she said. "Precision BioLogic is one our life sciences pioneers and it has set a standard for excellence that does all Nova Scotians proud." 

 BioPort Atlantic is an annual conference featuring life science business leaders and scientists, government representatives, entrepreneurs and investors, innovators and students from North America and abroad.

More details can be found at .

 Precision BioLogic designs, develops, manufactures and markets specialized medical products used to diagnose blood coagulation disorders. Its products are used in more than 1,000 laboratories across Canada, the United States and Europe. For more information, visit

 Nova Scotia Business Inc. is Nova Scotia's private-sector-led business development agency. NSBI is the investment-attraction arm of the province and helps businesses in Nova Scotia meet growth potential through advisory services, trade development, financing and venture capital.

Go to for more details.

Media Contact:

Cindy Roberts
Nova Scotia Business Inc.
Send Cindy a message